Skip to main content
Top
Published in: American Journal of Clinical Dermatology 3/2001

01-06-2001 | Adis New Drug Profile

Topical Eflornithine

A Viewpoint by Enrico Carmina

Author: Enrico Carmina

Published in: American Journal of Clinical Dermatology | Issue 3/2001

Login to get access

Excerpt

Treatment of hirsutism can be difficult and stressful because of the need to take systemic drugs, or to use expensive mechanical therapies, for prolonged periods without (at least in most patients) definitive results. A possible alternative is to use topical therapy. In the past the use of topical antiandrogens has been suggested, but without significant results. Recently, good results in localized hirsutism have been reported using eflornithine, an inhibitor of ornithine decarboxylase (an enzyme that has a major role in the biosynthesis of polyamines). While eflornithine was initially developed for the treatment of trypanosomal sleeping sickness, its topical administration slows hair follicle growth probably by inhibiting keratin protein synthesis. …
Metadata
Title
Topical Eflornithine
A Viewpoint by Enrico Carmina
Author
Enrico Carmina
Publication date
01-06-2001
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 3/2001
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200102030-00011

Other articles of this Issue 3/2001

American Journal of Clinical Dermatology 3/2001 Go to the issue

Review Article

Vitiligo

Adis New Drug Profile

Topical Eflornithine